Report Detail
Global Potassium Iodide Tablet Market Growth 2022-2028
- RnM4475165 |
- 02 August, 2022 |
- Global |
- 103 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global market for Potassium Iodide Tablet is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Potassium Iodide Tablet players cover Anbex, Inc, Recipharm, BTG Specialty Pharmaceuticals, NOW Foods and Life Extension, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Potassium Iodide Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Potassium Iodide Tablet market, with both quantitative and qualitative data, to help readers understand how the Potassium Iodide Tablet market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Potassium Iodide Tablet market and forecasts the market size by Specification (＜ 60mg, 60 - 90mg and ＞ 90mg), by Application (Pregnant or Breastfeeding Women, Adult and Child,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
＜ 60mg
60 - 90mg
＞ 90mg
Segmentation by application
Pregnant or Breastfeeding Women
Adult
Child
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Anbex, Inc
Recipharm
BTG Specialty Pharmaceuticals
NOW Foods
Life Extension
Pure Encapsulations
KI Canada Ltd
PCCA
Hexagon Nutrition
Healthvit
Chapter Introduction
Chapter 1: Scope of Potassium Iodide Tablet, Research Methodology, etc.
Chapter 2: Executive Summary, global Potassium Iodide Tablet market size (sales and revenue) and CAGR, Potassium Iodide Tablet market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Potassium Iodide Tablet sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Potassium Iodide Tablet sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Potassium Iodide Tablet market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Anbex, Inc, Recipharm, BTG Specialty Pharmaceuticals, NOW Foods, Life Extension, Pure Encapsulations, KI Canada Ltd, PCCA and Hexagon Nutrition and etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Potassium Iodide Tablet Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Potassium Iodide Tablet by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Potassium Iodide Tablet by Country/Region, 2017, 2022 & 2028
- 2.2 Potassium Iodide Tablet Segment by Specification
- 2.2.1 ＜ 60mg
- 2.2.2 60 - 90mg
- 2.2.3 ＞ 90mg
- 2.3 Potassium Iodide Tablet Sales by Specification
- 2.3.1 Global Potassium Iodide Tablet Sales Market Share by Specification (2017-2022)
- 2.3.2 Global Potassium Iodide Tablet Revenue and Market Share by Specification (2017-2022)
- 2.3.3 Global Potassium Iodide Tablet Sale Price by Specification (2017-2022)
- 2.4 Potassium Iodide Tablet Segment by Application
- 2.4.1 Pregnant or Breastfeeding Women
- 2.4.2 Adult
- 2.4.3 Child
- 2.5 Potassium Iodide Tablet Sales by Application
- 2.5.1 Global Potassium Iodide Tablet Sale Market Share by Application (2017-2022)
- 2.5.2 Global Potassium Iodide Tablet Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Potassium Iodide Tablet Sale Price by Application (2017-2022)
3 Global Potassium Iodide Tablet by Company
- 3.1 Global Potassium Iodide Tablet Breakdown Data by Company
- 3.1.1 Global Potassium Iodide Tablet Annual Sales by Company (2020-2022)
- 3.1.2 Global Potassium Iodide Tablet Sales Market Share by Company (2020-2022)
- 3.2 Global Potassium Iodide Tablet Annual Revenue by Company (2020-2022)
- 3.2.1 Global Potassium Iodide Tablet Revenue by Company (2020-2022)
- 3.2.2 Global Potassium Iodide Tablet Revenue Market Share by Company (2020-2022)
- 3.3 Global Potassium Iodide Tablet Sale Price by Company
- 3.4 Key Manufacturers Potassium Iodide Tablet Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Potassium Iodide Tablet Product Location Distribution
- 3.4.2 Players Potassium Iodide Tablet Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Potassium Iodide Tablet by Geographic Region
- 4.1 World Historic Potassium Iodide Tablet Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Potassium Iodide Tablet Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Potassium Iodide Tablet Annual Revenue by Geographic Region
- 4.2 World Historic Potassium Iodide Tablet Market Size by Country/Region (2017-2022)
- 4.2.1 Global Potassium Iodide Tablet Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Potassium Iodide Tablet Annual Revenue by Country/Region
- 4.3 Americas Potassium Iodide Tablet Sales Growth
- 4.4 APAC Potassium Iodide Tablet Sales Growth
- 4.5 Europe Potassium Iodide Tablet Sales Growth
- 4.6 Middle East & Africa Potassium Iodide Tablet Sales Growth
5 Americas
- 5.1 Americas Potassium Iodide Tablet Sales by Country
- 5.1.1 Americas Potassium Iodide Tablet Sales by Country (2017-2022)
- 5.1.2 Americas Potassium Iodide Tablet Revenue by Country (2017-2022)
- 5.2 Americas Potassium Iodide Tablet Sales by Specification
- 5.3 Americas Potassium Iodide Tablet Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Potassium Iodide Tablet Sales by Region
- 6.1.1 APAC Potassium Iodide Tablet Sales by Region (2017-2022)
- 6.1.2 APAC Potassium Iodide Tablet Revenue by Region (2017-2022)
- 6.2 APAC Potassium Iodide Tablet Sales by Specification
- 6.3 APAC Potassium Iodide Tablet Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Potassium Iodide Tablet by Country
- 7.1.1 Europe Potassium Iodide Tablet Sales by Country (2017-2022)
- 7.1.2 Europe Potassium Iodide Tablet Revenue by Country (2017-2022)
- 7.2 Europe Potassium Iodide Tablet Sales by Specification
- 7.3 Europe Potassium Iodide Tablet Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Potassium Iodide Tablet by Country
- 8.1.1 Middle East & Africa Potassium Iodide Tablet Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Potassium Iodide Tablet Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Potassium Iodide Tablet Sales by Specification
- 8.3 Middle East & Africa Potassium Iodide Tablet Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Potassium Iodide Tablet
- 10.3 Manufacturing Process Analysis of Potassium Iodide Tablet
- 10.4 Industry Chain Structure of Potassium Iodide Tablet
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Potassium Iodide Tablet Distributors
- 11.3 Potassium Iodide Tablet Customer
12 World Forecast Review for Potassium Iodide Tablet by Geographic Region
- 12.1 Global Potassium Iodide Tablet Market Size Forecast by Region
- 12.1.1 Global Potassium Iodide Tablet Forecast by Region (2023-2028)
- 12.1.2 Global Potassium Iodide Tablet Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Potassium Iodide Tablet Forecast by Specification
- 12.7 Global Potassium Iodide Tablet Forecast by Application
13 Key Players Analysis
- 13.1 Anbex, Inc
- 13.1.1 Anbex, Inc Company Information
- 13.1.2 Anbex, Inc Potassium Iodide Tablet Product Offered
- 13.1.3 Anbex, Inc Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Anbex, Inc Main Business Overview
- 13.1.5 Anbex, Inc Latest Developments
- 13.2 Recipharm
- 13.2.1 Recipharm Company Information
- 13.2.2 Recipharm Potassium Iodide Tablet Product Offered
- 13.2.3 Recipharm Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Recipharm Main Business Overview
- 13.2.5 Recipharm Latest Developments
- 13.3 BTG Specialty Pharmaceuticals
- 13.3.1 BTG Specialty Pharmaceuticals Company Information
- 13.3.2 BTG Specialty Pharmaceuticals Potassium Iodide Tablet Product Offered
- 13.3.3 BTG Specialty Pharmaceuticals Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 BTG Specialty Pharmaceuticals Main Business Overview
- 13.3.5 BTG Specialty Pharmaceuticals Latest Developments
- 13.4 NOW Foods
- 13.4.1 NOW Foods Company Information
- 13.4.2 NOW Foods Potassium Iodide Tablet Product Offered
- 13.4.3 NOW Foods Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 NOW Foods Main Business Overview
- 13.4.5 NOW Foods Latest Developments
- 13.5 Life Extension
- 13.5.1 Life Extension Company Information
- 13.5.2 Life Extension Potassium Iodide Tablet Product Offered
- 13.5.3 Life Extension Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Life Extension Main Business Overview
- 13.5.5 Life Extension Latest Developments
- 13.6 Pure Encapsulations
- 13.6.1 Pure Encapsulations Company Information
- 13.6.2 Pure Encapsulations Potassium Iodide Tablet Product Offered
- 13.6.3 Pure Encapsulations Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Pure Encapsulations Main Business Overview
- 13.6.5 Pure Encapsulations Latest Developments
- 13.7 KI Canada Ltd
- 13.7.1 KI Canada Ltd Company Information
- 13.7.2 KI Canada Ltd Potassium Iodide Tablet Product Offered
- 13.7.3 KI Canada Ltd Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 KI Canada Ltd Main Business Overview
- 13.7.5 KI Canada Ltd Latest Developments
- 13.8 PCCA
- 13.8.1 PCCA Company Information
- 13.8.2 PCCA Potassium Iodide Tablet Product Offered
- 13.8.3 PCCA Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 PCCA Main Business Overview
- 13.8.5 PCCA Latest Developments
- 13.9 Hexagon Nutrition
- 13.9.1 Hexagon Nutrition Company Information
- 13.9.2 Hexagon Nutrition Potassium Iodide Tablet Product Offered
- 13.9.3 Hexagon Nutrition Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Hexagon Nutrition Main Business Overview
- 13.9.5 Hexagon Nutrition Latest Developments
- 13.10 Healthvit
- 13.10.1 Healthvit Company Information
- 13.10.2 Healthvit Potassium Iodide Tablet Product Offered
- 13.10.3 Healthvit Potassium Iodide Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Healthvit Main Business Overview
- 13.10.5 Healthvit Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Potassium Iodide Tablet. Industry analysis & Market Report on Potassium Iodide Tablet is a syndicated market report, published as Global Potassium Iodide Tablet Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Potassium Iodide Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
